20040095.TNBC
— · E
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- E
- subtype
- E
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- G2M_CHECKPOINT+0.360
- NOTCH_SIGNALING+0.330
- E2F_TARGETS+0.320
- MITOTIC_SPINDLE+0.280
- WNT_BETA_CATENIN_SIGNALING+0.220
- MYC_TARGETS_V2+0.170
- DNA_REPAIR+0.120
- KRAS_SIGNALING_DN+0.100
- SPERMATOGENESIS+0.080
- MYOGENESIS+0.030
Top 10 suppressed
- INTERFERON_ALPHA_RESPONSE-0.680
- INTERFERON_GAMMA_RESPONSE-0.600
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.560
- ALLOGRAFT_REJECTION-0.520
- INFLAMMATORY_RESPONSE-0.510
- COMPLEMENT-0.460
- ANGIOGENESIS-0.430
- COAGULATION-0.430
- IL6_JAK_STAT3_SIGNALING-0.420
- APOPTOSIS-0.410
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
6 twins match this tumor's tissue · 4 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR8518343 | — | E | 0.910 |
| 2 | BS_PQVTB6BB | high-grade glioma | — | 0.908 |
| 3 | ERR2208946 | — | — | 0.907 |
| 4 | MDT-AP-1138 | Med | Medulloblastoma | 0.903 |
| 5 | C3N-03886 | — | cohortMD1 | 0.901 |
| 6 | SJEPD031175_D1.RNA-Seq | EPN | Posterior Fossa EPN | 0.901 |
| 7 | TCGA-56-A4BX-01A-11R-A24H-07 | — | cohortSQ2 | 0.899 |
| 8 | BS_VAAHBH60 | Supratentorial Ependymoma | — | 0.898 |
| 9 | TCGA-98-A53A-01A-11R-A262-07 | — | cohortSQ1 | 0.896 |
| 10 | SRR8613777 | — | D | 0.891 |